why choose us

First received: August 01, 2023

Clinical Trial: Lamivudine and Plasma Markers of Inflammation in Retinal Detachment

Study Status: Completed

Recruit Status: RECRUITING

Condition: Retinal Detachment

Study Type: INTERVENTIONAL


Official Title: Intra-ocular Penetration of Oral Lamivudine and Measurement of Systemic Inflammatory Markers in Patients Undergoing Rhegmatogenous Retinal Detachment Surgery

Brief Summary: The goal of this clinical trial is to test whether an oral medication (lamivudine) enters the eye and reduces blood markers of inflammation in people who undergo retinal detachment surgery (pars plana vitrectomy).Participants will take the study medication or placebo, and the researchers will measure blood markers of inflammation before and after surgery.The researchers will also measure the amount of medication in the blood and fluid inside the participant's eye (which is collected during surgery).

Read more